Ascend Laboratories, LLC secured FDA approval for its generic Methadone Hydrochloride product, a move expected to bolster the company's footprint in the opioid dependence treatment market. By establishing a low-cost alternative to existing branded products, Ascend is poised to gain market share and drive revenue growth.